News from the healthcare data industry
Working together on the world’s first treatment that targets the underlying causes of pyruvate kinase (“PK”) deficiency in children under the age of 18 June 13, 2022 06:30 ET | Source: Centogene...
June 09, 2022 10:00 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration sponsored by Eli Lilly and Company designed...
SAN FRANCISCO and FORT LAUDERDALE, Fla., June 07, 2022 (GLOBE NEWSWIRE) — The COVID-19 Research Database (the Database), a pro bono initiative led by numerous prominent companies whose mission is...
Singapore – 7 June 2022: GE Healthcare today announces a new collaboration with National Cancer Centre Singapore (NCCS), which focuses on how artificial intelligence (AI) driven research can be used to...
Initial Goal of Collaboration is to Develop FoundationOne®Liquid CDx as a Companion Diagnostic for Bavdegalutamide (ARV-110), Arvinas’ Investigational Androgen Receptor-Targeting PROTAC® Protein Degrader June 05, 2022 08:05 AM Eastern Daylight...
COBALT study in advanced PBC, previously terminated early due to feasibility challenges, did not demonstrate a statistically significant difference in clinical endpoints between Ocaliva® and placebo HEROES-US real-world analysis demonstrated statistically...
LEADER Trial Will Use Results from Foundation Medicine’s Comprehensive Genomic Profiling Tests to Screen for Actionable Driver Mutations to Inform Trial Enrollment and Targeted Therapy Options for Patients New “Trial...
CHICAGO, IL, UNITED STATES, June 3, 2022 /EINPresswire.com/ — Today, at the annual meeting of the American Society of Clinical Oncology (ASCO), Prognos Health and xCures announced a collaboration to...
June 03, 2022 Vancouver, BC — Genomic research is leading to incredible advances in modern-day healthcare but combining health and genomic data can greatly accelerate new discoveries. To enable the advancement...